Katharine Dilger

Title: Katharine Dilger – Innovator in Hybridization Capture Technologies

Introduction

Katharine Dilger, based in Foster City, California, is a dedicated inventor with a focus on advancements in molecular biology techniques. Known for her innovative contributions to hybridization capture methods, Dilger has made significant strides in enhancing the efficiency of nucleic acid analyses, particularly in Next Generation Sequencing (NGS) applications.

Latest Patents

Dilger holds a patent titled "Hybridization Capture Methods and Compositions." This invention provides a novel approach to enriching target nucleic acid sequences from a larger population of nucleic acids. The described methods enable the effective hybridization of target nucleic acids to capture probes and include steps that facilitate the denaturation of unwanted nucleic acids, thereby enriching the sample for desirable sequences. This innovation has essential applications in genetic research and diagnostics, significantly contributing to the field's advancement.

Career Highlights

Katharine Dilger is affiliated with Integrated DNA Technologies, Inc., where she has applied her expertise to develop cutting-edge solutions in the genomic field. Her work not only exhibits her strong dedication to innovation but also emphasizes the importance of collaboration in scientific research and development.

Collaborations

Throughout her career, Dilger has collaborated with talented colleagues such as Alexandra Hui Wang and Rachael Cunningham. Their joint efforts highlight the teamwork essential for driving forward impactful scientific innovations and the importance of diverse expertise in complex projects.

Conclusion

Katharine Dilger’s innovative spirit and commitment to improving hybridization capture technologies mark her as an influential figure in the realm of molecular biology. Her patent reflects a significant contribution to enhancing the capabilities of genetic analysis, paving the way for future advancements in the field. As she continues her work with Integrated DNA Technologies, Inc., Dilger undoubtedly remains a key player in the innovation landscape of genomic research.